Stock News
“Unleashing the Power of Amazon: A Recap of AMZN’s Q4 2024 Earnings Call”
Amazon.com, Inc. (NASDAQ:AMZN ) Q4 2024 Earnings Conference Call Analysis Key Players in the Conference Call During the Amazon.com Fourth Quarter 2024 Financial Results Teleconference, several key players were present to discuss the company’s performance and future strategies. These included Dave Fildes, the VP of Investor Relations, Andy Jassy, the CEO, and Brian Olsavsky, the…
Charmingly Eccentric and Engaging: Levi and Korsinsky Investigates B-981196 for OLED Alert
Investigation of Universal Display Corporation Charmingly eccentric, full of personality, and designed for maximum reader engagement NEW YORK, NY / ACCESS Newswire / February 6, 2025 Levi & Korsinsky notifies investors that it has commenced an investigation of Universal Display Corporation concerning possible violations of federal securities laws. On August 1, 2024, Universal reported solid…
“Attention NMRA Shareholders and Investors: Don’t Let Neumora-T Be the One That Got Away!”
Levi & Korsinsky Investigates Neumora Therapeutics, Inc. New York, NY / ACCESS Newswire / February 6, 2025 Neumora Therapeutics, Inc. Under Scrutiny for Potential Securities Law Violations Levi & Korsinsky has recently announced that they have started an investigation into Neumora Therapeutics, Inc. concerning possible breaches of federal securities laws. This follows Neumora’s announcement on…
“Unlocking the Future: A Recap of Affirm Holdings Inc.’s Q2 2025 Earnings Call”
Affirm Holdings, Inc. Q2 2025 Earnings Conference Call Overview Company Participants: Zane Keller – Director, IR Max Levchin – Founder & CEO Michael Linford – COO Rob O’Hare – CFO Conference Call Participants: Ramsey El-Assal – Barclays Will Nance – Goldman Sachs Matt O’Neill – FT Partners Dan Dolev – Mizuho Securities Kyle Peterson –…
“Unleashing the Power of Regeneron: Rosen Investor Counsel Urges Business Professionals to Take Notice”
Regeneron Pharmaceuticals, Inc. Securities Alert: Rosen Law Firm Reminds Investors of March 10 Deadline Why You Should Take Note Rosen Law Firm, a global investor rights law firm, is reminding purchasers of securities of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) between November 2, 2023 and October 30, 2024, both dates inclusive (the “Class Period”), of the important…
“Disappointing Results: Matthews International Falls Short of Q1 Earnings and Revenue Estimates”
Understanding Matthews International (MATW) Earnings Report A Closer Look at the Numbers Matthews International recently announced their quarterly earnings report, revealing that they earned $0.14 per share. This fell short of the Zacks Consensus Estimate of $0.26 per share, and is a significant decrease from the $0.37 per share earnings reported a year ago. Analysis…
“Boyd Gaming Corporation (BYD) Q4 2024 Earnings Call: A Playful Peek into the Numbers”
Welcome to the Boyd Gaming Corporation Q4 2024 Earnings Conference Call Introduction Good afternoon, and welcome to the Boyd Gaming Fourth Quarter and Full Year 2024 Earnings Conference Call. My name is David Strow, Vice President of Corporate Communications for Boyd Gaming. Today, we will be discussing our performance in the fourth quarter of 2024…
“Calling All Red Cat Investors: Don’t Miss Out on Potential Compensation! Rosen Law Firm Launches Investigation into RCAT Securities Class Action”
Welcome to the Rosen Law Firm Blog! An Investigation into Red Cat Holdings, Inc. New York – Feb. 6, 2025 Rosen Law Firm, a global investor rights law firm, has recently announced an investigation of potential securities claims on behalf of shareholders of Red Cat Holdings, Inc. (NASDAQ: RCAT). The investigation comes as a result…